drugset / Trial / NCT02302456

Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery

NCT02302456 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to assess whether the administration of a low dose of tranexamic acid just after vaginal delivery can reduce the incidence of immediate postpartum hemorrhage, in women who receive a prophylactic administration of oxytocin.

Timeline

Start
2015-02
Primary completion
2017-01
Completion
2017-04

Outcome

Missed primary endpoint

paper did not result in a rate of postpartum hemorrhage of at least 500 ml that was significantly lower than the rate with placebo. PMID 30134136 ↗

paper relative risk, 0.83; 95% confidence interval [CI], 0.68 to 1.01; P=0.07 PMID 30134136 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications